TickerFacts.

Fennec Pharmaceuticals Inc. (FENC): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-18, first reflected in a filing dated 2011-11-14; 1-for-3, first reflected in a filing dated 2014-11-13. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

28.58M
Year ended 2025-12-31
+2.8%
3-year compound annual growth
+3.8%
5-year compound annual growth
+10.2%
10-year compound annual growth
2010-12-31: 16.02M2011-12-31: 24.05M2012-12-31: 25.16M2013-12-31: 10.57M2014-12-31: 9.87M2015-12-31: 10.83M2016-12-31: 12.77M2017-12-31: 15.01M2018-12-31: 18.94M2019-12-31: 19.90M2020-12-31: 23.70M2021-12-31: 26.01M2022-12-31: 26.27M2023-12-31: 26.57M2024-12-31: 27.29M2025-12-31: 28.58M28.58M
2010-12-31 Weighted Average Diluted Shares (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3128.58M+4.7%2026-03-27, From 2025-01-01
2024-12-3127.29M+2.7%2026-03-27, From 2024-01-01
2023-12-3126.57M+1.1%2025-03-26, From 2023-01-01
2022-12-3126.27M+1.0%2024-03-29, From 2022-01-01
2021-12-3126.01M+9.7%2023-03-29, From 2021-01-01
2020-12-3123.70M+19.1%2021-03-30, From 2020-01-01
2019-12-3119.90M+5.0%2021-03-30, From 2019-01-01
2018-12-3118.94M+26.2%2020-02-14, From 2018-01-01
2017-12-3115.01M+17.6%2019-03-15, From 2017-01-01
2016-12-3112.77M+17.9%2018-03-28, From 2016-01-01
2015-12-3110.83M+9.7%2017-03-29, From 2015-01-01
2014-12-319.87M-6.6%2016-03-28, From 2014-01-01
2013-12-3110.57Mn/c2015-03-31, From 2013-01-01
2012-12-3125.16M+4.6%2014-03-31, From 2012-01-01
2011-12-3124.05M+50.2%2012-03-27, From 2011-01-01
2010-12-3116.02Mn/a2012-03-27, From 2010-01-01